Delivery Order SPE2DB20D3104-SPE2DB25FV9D0
- Not listed
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $5,025.52 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561692704 Jardiance 10 mg tablets, 90 count, to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 3 to August 4, 2023. As a major distributor of pharmaceuticals and medical supplies for the military,...
- The Defense Logistics Agency awarded a delivery order valued at $10,844.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which is not set-aside, represents a single pharmaceutical procurement under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,732.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 25, 2025, with completion scheduled for July 28, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $10,700.20. The order, with an ultimate completion date of July 21, 2025, was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery to support federal medical procurement needs....
- The Defense Logistics Agency awarded a delivery order valued at $23,198.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with a completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,052.70 to Amerisourcebergen Drug Corporation for the supply of 4561787249 Jardiance 25 mg tablets. Under the terms of the order, Amerisourcebergen will deliver 90 tablets of the specified medication to a facility located in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. The Defense Logistics Agency routinely issues such orders under various prime vendor contracts to support the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,128.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. Issued on July 18, 2025, with an ultimate completion date of July 21, 2025, this firm fixed-price contract represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $13,903.72 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561542235 Jardiance 25 MG tablets, 90 count, to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 19-20, 2023. As a leading provider of pharmaceuticals and medical supplies,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract, valued at $2,274.14, covers the supply of Jardiance 25 mg tablets in quantities of 90, a diabetes medication used extensively across the military healthcare system. This non-competitive, firm fixed price delivery order represents a routine...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9D0Delivery Order
The Defense Logistics Agency awarded a $12.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, providing military and veteran healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. The contract vehicle demonstrates AmerisourceBergen's significant role in federal pharmaceutical procurement and its capability to fulfill diverse medical supply requirements through open competition alongside other prime vendors in DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 7/25/25 |